Showing results (991-1000 of 3,103) with videos related to

Sort By:
Pageof 311
Drug Safety|June 1, 1996
Drug-induced methaemoglobinaemia. Treatment issuesM D Coleman, N A Coleman
Drug Safety|November 1, 1995
Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatmentJ M Klafta, J P Zacny, C J Young
Drug Safety|November 1, 1995
Risks and benefits of interferon-alpha in the treatment of hepatitisM Pardo, E Marriott, M C Moliner, et al.
Drug Safety|November 1, 1995
A risk-benefit assessment of teicoplanin in the treatment of infectionsF de Lalla, A Tramarin
Drug Safety|November 14, 2016
Active Surveillance of Follow-on Biologics: A Prescription for UptakeAmeet Sarpatwari, Joshua J Gagne, Nicole L Levidow, et al.
Drug Safety|November 20, 2016
The Harms of Antipsychotic Drugs: Evidence from Key StudiesThomas J Moore, Curt D Furberg
Drug Safety|December 19, 2016
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in FranceMarine Auffret, Julien Labreuche, Alain Duhamel, et al.
Drug Safety|October 11, 2016
From the Uppsala Monitoring Centre : A Review of Viewpoint Part 1 and Part 2Bruce Hugman
Drug Safety|December 23, 2016
Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a TollGuillermo Prada-Ramallal, Bahi Takkouche, Adolfo Figueiras
Drug Safety|March 22, 2017
Targeting Interleukin-5 or Interleukin-5Rα: Safety ConsiderationsDiego Bagnasco, Matteo Ferrando, Marco Caminati, et al.
Pageof 311